Filing Details
- Accession Number:
- 0001104659-24-025684
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 19:52:18
- Reporting Period:
- 2024-02-20
- Accepted Time:
- 2024-02-20 19:52:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1425205 | Iovance Biotherapeutics Inc. | IOVA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1210317 | A Merrill Mcpeak | C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, 4Th Floor San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-20 | 250,000 | $9.15 | 320,150 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 248,633 | Indirect | By Trust |
Footnotes
- These shares are held by a family trust for which the reporting person is a trustee.
- Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.
- Such number does not include 103,159 deferred restricted stock units, which are vested but not yet issued.
- Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering.